Listed

Ainos, Inc.: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 17, 2019 and accepted by EDGAR at May 17, 2019, 16:43 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-01-01 to 2019-03-31$4.1kus-gaap:Revenues
Cost of revenue3 months2019-01-01 to 2019-03-31$2.7kus-gaap:CostOfRevenue
Gross profit3 months2019-01-01 to 2019-03-31$1.4kus-gaap:GrossProfit
Research and development3 months2019-01-01 to 2019-03-31$2.4kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-01-01 to 2019-03-31$389.5kus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-01-01 to 2019-03-31−$390.5kus-gaap:OperatingIncomeLoss
Interest expense3 months2019-01-01 to 2019-03-31$885us-gaap:InterestExpense
Net income3 months2019-01-01 to 2019-03-31−$391.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2019-01-01 to 2019-03-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2019-01-01 to 2019-03-31−$216.2kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2019-01-01 to 2019-03-31$1.6kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-03-31$1.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$1.1mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$1.2mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$673.8kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$673.8kus-gaap:Liabilities

Source: SEC EDGAR, the filing index for accession 0001014763-19-000007. Last ingested by Listed: Nov 11, 2026, 00:28 ET. Listed shows no prices and gives no investment advice.